TPT1 pseudogene 2 (TPT1P2)

TPT1 pseudogene 2 (TPT1P2) is one of several intronless, processed pseudogenes derived from the TPT1 gene, which encodes the translationally controlled tumor protein (TCTP)[1]. Though the parent TPT1 gene is widely expressed and involved in cell proliferation, apoptosis, and cancer biology[3][5][7], pseudogenes like TPT1P2 do not encode functional proteins and typically do not participate directly in those cellular pathways or disease processes. Some pseudogenes can exert regulatory effects on their parental genes or function as noncoding RNAs, but no such role has been established for TPT1P2[1][6]. As such, it is not considered a molecular target for therapeutic intervention, nor is it relevant for drug interaction, disease biomarker use, or mechanism-of-action studies. Summary of issues: - TPT1P2 is not an active protein or receptor, making its role as a therapeutic target invalid[1][6]. - Structured information sought for drug discovery or biomarker purposes is not applicable to pseudogenes like TPT1P2[1][6]. - Disease roles, interactions, and functional descriptions available for TPT1 refer to the original TPT1 protein-coding gene, not the pseudogene[3][5][7].

Other names

TPT1P2TCTP pseudogene 2